Relationship between NADH and NADPH oxidation during drug metabolism.
D000818:Animals; D000918:Antibody Specificity; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000378:metabolism; D003580:Cytochromes / Q000378:metabolism; D003640:Dealkylation; D006041:Goats / Q000276:immunology; D008862:Microsomes, Liver / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D009019:Morphinans / Q000378:metabolism; D009243:NAD / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010634:Phenobarbital / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D005719:gamma-Globulins
D003580:Cytochromes; D009019:Morphinans; D004364:Pharmaceutical Preparations; D005719:gamma-Globulins; D009243:NAD; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D003579:Cytochrome Reductases; D010634:Phenobarbital